Stockreport

Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for [Read more]